search
Back to results

The Effect of Remote Ischemic Preconditioning in the Cardiac Surgery (RIPC)

Primary Purpose

Myocardium; Injury, Cardiac Surgical Procedures

Status
Completed
Phase
Phase 1
Locations
Korea, Republic of
Study Type
Interventional
Intervention
remote ischemic preconditioning
Sponsored by
Seoul National University Hospital
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional prevention trial for Myocardium; Injury focused on measuring RIPC, cardiac surgery, ischemic preconditioning, cardiac surgical procedures

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • adult patients undergoing cardiac surgery

Exclusion Criteria:

  • emergent operation
  • preoperative use of inotropics or mechanical assist device,
  • left ventricular ejection fraction less than 30%,
  • severe liver, renal and pulmonary disease,
  • recent myocardial infarction (within 7 days),
  • recent systemic infection or sepsis (within 7 days)
  • peripheral vascular disease affecting upper limbs
  • amputation of the upper limbs
  • major combined operation such as aortic surgery or carotid endarterectomy
  • descending thoracic aortic surgery
  • rare surgeries; cardiac transplantation, correction of complicated congenital anomalies, pulmonary thromboembolectomy, etc

Sites / Locations

  • Seoul National University Hospital

Outcomes

Primary Outcome Measures

In-hospital death
Myocardial infarction
Stroke
Respiratory failure
Renal dysfunction
Renal failure
Cardiogenic shock
Gastrointestinal complication

Secondary Outcome Measures

Length of ICU stay
Length of postoperative hospital stay

Full Information

First Posted
October 15, 2009
Last Updated
February 22, 2011
Sponsor
Seoul National University Hospital
Collaborators
Asan Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00997217
Brief Title
The Effect of Remote Ischemic Preconditioning in the Cardiac Surgery
Acronym
RIPC
Official Title
The Effect of Remote Ischemic Preconditioning on Mortality and Morbidity in Cardiac Surgery: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2011
Overall Recruitment Status
Completed
Study Start Date
October 2009 (undefined)
Primary Completion Date
September 2010 (Actual)
Study Completion Date
November 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Seoul National University Hospital
Collaborators
Asan Medical Center

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Perioperative myocardial injury is a serious complication of cardiac surgery. This complication increases both mortality and morbidity of cardiac surgery. Remote ischemic preconditioning (RIPC) is the concept that brief ischemia followed by reperfusion in an organ can reduce subsequent ischemia-reperfusion injury in distant organs. Recent several clinical trials showed powerful myocardial protective effect of remote ischemic preconditioning by reducing postoperative cardiac enzymes. However, the evidence that remote ischemic preconditioning can improve the clinical outcomes such as mortality and morbidity, is still lacking. The investigators perform a multicenter randomized controlled study to evaluate that remote ischemic preconditioning can improve the outcomes of cardiac surgery.
Detailed Description
Perioperative myocardial injury is a serious complication of cardiac surgery. This complication increases both mortality and morbidity of cardiac surgery. Remote ischemic preconditioning (RIPC) is the concept that brief ischemia followed by reperfusion in an organ can reduce subsequent ischemia-reperfusion injury in distant organs. Recent several clinical trials showed powerful myocardial protective effect of remote ischemic preconditioning by reducing postoperative cardiac enzymes. However, the evidence that remote ischemic preconditioning can improve the clinical outcomes such as mortality and morbidity, is still lacking. The investigators perform a multicenter randomized controlled study to evaluate that remote ischemic preconditioning can improve the outcomes of cardiac surgery. Purpose: The purpose of this study is to examine if remote ischemic preconditioning can decrease the mortality and fatal postoperative complications in patients undergoing cardiac surgery. The effect will be assessed by mortality, severe morbidities and duration of hospital stay. Methods: Study patients will be randomized to cardiac surgery with RIPC or conventional cardiac surgery in two cardiac surgical centers (Seoul National University Hospital and Asan Medical Center). Remote ischemic preconditioning consists of four 5 min cycles of upper limb ischemia and reperfusion with pneumatic cuff up to 200 mmHg. RIPC is performed twice: before and after the coronary anastomosis in off-pump coronary bypass graft surgery; or before and after the cardiopulmonary bypass in the cardiac valve surgery. Primary study outcome is in-hospital death within 30 postoperative days and fatal postoperative complications such as myocardial infarction, stoke, respiratory failure, renal failure, cardiogenic shock and gastrointestinal complications. Secondary outcomes include the length of intensive care unit (ICU) stay and hospital stay.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myocardium; Injury, Cardiac Surgical Procedures
Keywords
RIPC, cardiac surgery, ischemic preconditioning, cardiac surgical procedures

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
1200 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
remote ischemic preconditioning
Other Intervention Name(s)
Blood pressure pneumatic cuff
Intervention Description
remote ischemic preconditioning (4 x 5 min upper limb ischemia with pneumatic cuff up to 200 mmHg with an intervening 5 min reperfusion; 2 cycles; before and after the coronary anastomosis or cardiopulmonary bypass)
Primary Outcome Measure Information:
Title
In-hospital death
Time Frame
Postoperative 30 days
Title
Myocardial infarction
Time Frame
Postoperative 30 days
Title
Stroke
Time Frame
Postoperative 30 days
Title
Respiratory failure
Time Frame
Postoperative 30 days
Title
Renal dysfunction
Time Frame
Postoperative 30 days
Title
Renal failure
Time Frame
Postoperative 30 days
Title
Cardiogenic shock
Time Frame
Postoperative 30 days
Title
Gastrointestinal complication
Time Frame
Postoperative 30 days
Secondary Outcome Measure Information:
Title
Length of ICU stay
Time Frame
Postoperative 3 months
Title
Length of postoperative hospital stay
Time Frame
Postoperative 3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: adult patients undergoing cardiac surgery Exclusion Criteria: emergent operation preoperative use of inotropics or mechanical assist device, left ventricular ejection fraction less than 30%, severe liver, renal and pulmonary disease, recent myocardial infarction (within 7 days), recent systemic infection or sepsis (within 7 days) peripheral vascular disease affecting upper limbs amputation of the upper limbs major combined operation such as aortic surgery or carotid endarterectomy descending thoracic aortic surgery rare surgeries; cardiac transplantation, correction of complicated congenital anomalies, pulmonary thromboembolectomy, etc
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
YunSeok Jeon, professor
Organizational Affiliation
Department of Anesthesiology and Pain Medicine, SNUH
Official's Role
Study Director
Facility Information:
Facility Name
Seoul National University Hospital
City
Seoul
ZIP/Postal Code
110-744
Country
Korea, Republic of

12. IPD Sharing Statement

Citations:
PubMed Identifier
28043669
Citation
Cho YJ, Lee EH, Lee K, Kim TK, Hong DM, Chin JH, Choi DK, Bahk JH, Sim JY, Choi IC, Jeon Y. Long-term clinical outcomes of Remote Ischemic Preconditioning and Postconditioning Outcome (RISPO) trial in patients undergoing cardiac surgery. Int J Cardiol. 2017 Mar 15;231:84-89. doi: 10.1016/j.ijcard.2016.12.146. Epub 2016 Dec 23.
Results Reference
derived
PubMed Identifier
24014392
Citation
Hong DM, Lee EH, Kim HJ, Min JJ, Chin JH, Choi DK, Bahk JH, Sim JY, Choi IC, Jeon Y. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. Eur Heart J. 2014 Jan;35(3):176-83. doi: 10.1093/eurheartj/eht346. Epub 2013 Sep 7.
Results Reference
derived

Learn more about this trial

The Effect of Remote Ischemic Preconditioning in the Cardiac Surgery

We'll reach out to this number within 24 hrs